EMBODY BIOSIGNALS LIMITED
Significant control: Christopher James (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Embody Biosignals Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Embody Biosignals Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
EMBODY BIOSIGNALS LIMITED is an active private limited company (company number 09742798) incorporated on 21 August 2015, registered in Nottingham. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 August 2025, showing net assets of −£2,715, with 1 employee on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 19% on the prior period (−£3,361).
By net assets it sits in the bottom quarter of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).
Ownership and control
- Dr Christopher James
- owns 75–100% of shares
- holds 75–100% of voting rights
- holds 75–100% of voting rights
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 21 August 201511 yrs ago
- Next accounts due
- 31 May 2027in 215 days
- Confirmation statement due
- 4 September 2027in 311 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 August 2025 | −£2,715 | — | — | — | — | — | 1 |
| 31 August 2024 | −£3,361 | — | — | — | — | — | 1 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets below zeroNet assets £-2,715 at 31 August 2025
- Net assets up 10% or more on the prior period+19.2% vs prior period
- Incorporated five or more years agoIncorporated 21 August 2015
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 311 days
- Next accounts duein 215 days
- Accounts period endNet liabilities £2,715 · micro accounts
- Accounts period endNet liabilities £3,361 · micro accounts
- Incorporated
Similar companies in Nottingham
- QUOTIENT SCIENCES (ALNWICK) LIMITEDNottingham · inc. Sept 2015
- CELLOMATICS BIOSCIENCES LIMITEDColwick · inc. Sept 2015
- WATCH BIDCO LIMITEDNottingham · inc. Nov 2015
- SELENTUS SCIENCE LIMITEDGrantham · inc. Apr 2016
- NESTTECK LTDMansfield · inc. Apr 2016
- EXCELLERATE BIOSCIENCE LIMITEDNottingham · inc. Jun 2016
All companies incorporated on 21 August 2015 · in Aug 2015.
Reminders for EMBODY BIOSIGNALS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.